Chemo - Laboratories Leon Farma S.A - Birth Control CF
CHEMO/Exeltis is very pleased to announce FDA's approval of the Slynd (drosperinone) for prescription use in the United States.
AbbVie - Endometriosis
AbbVie receives U.S. FDA Approval of ORILISSA (elagolix) for the Management of Monderate to Severe Pain Associated with Endometriosis.
Endoceutics- Vaginal Atrophy
Endoceutics® Receives Health Canada Approval for Intraraosa®. The first innovative drug for the treatment of vulvovaginal atrophy with prasterone.
Regeneron
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis
